Increased vascular endothelial growth factor levels in aqueous humor and serum of patients with quiescent uveitis

European Journal of Ophthalmology

Volumn 17, Issue 6, 2007, Pages 938-942

  Paroli, M P ^a   Teodori, C ^a   D'Alessandro, M ^a   Mariani, P ^a   Iannucci, G ^a   Paroli, Marino ^a  

^a POLICLINICO UMBERTO I   (Italy)

Author keywords

Interleukin 8; Uveitis; Vascular endothelial growth factor

Indexed keywords

INTERLEUKIN 8; VASCULOTROPIN;

ADULT; AGED; ANKYLOSING SPONDYLITIS; AQUEOUS HUMOR; ARTICLE; BEHCET DISEASE; BLOOD LEVEL; CLINICAL ARTICLE; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PATHOGENESIS; PRIORITY JOURNAL; UVEITIS; VOGT KOYANAGI SYNDROME;

EID: 39349111700     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210701700611     Document Type: Article

References (18)

1. Forrester JV. Uveitis: pathogenesis. Lancet 1991; 338: 1498-501.
2. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003; 9: 669-76.
3. Bates DO, Hillman NJ, Williams B, Neal CR, Pocock TM. Regulation of microvascular permeability by vascular endothelial growth factors. J Anat 2002; 200: 581-97.
4. Clavel G, Bessis N, Lemeiter D, et al. Angiogenesis markers (VEGF, soluble receptor of VEGF and angiopoietin-1) in very early arthritis and their association with inflammation and joint destruction. Clin Immunol 2007 [Epub ahead of print].
5. Arden GB, Sidman RL, Arap W, Schlingemann RO. Spare the rod and spoil the eye. Br J Ophthalmol 2005; 89: 764-9.
6. Vinores SA, Youssri AI, Luna JD, et al. Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease. Histol Histopathol 1997; 12: 99-109.
7. Vinores SA, Chan CC, Vinores MA, et al. Increased vascular endothelial growth factor (VEGF) and transforming growth factor beta (TGFbeta) in experimental autoimmune uveoretinitis: upregulation of VEGF without neovascularization. J Neuroimmunol 1998; 89: 43-50.
8. Cekmen M, Evereklioglu C, Er H, et al. Vascular endothelial growth factor levels are increased and associated with disease activity in patients with Behçet's syndrome. Int J Dermatol 2003; 42: 870-5.
9. Erdem F, Gundogdu M, Kiki I, Ali Sari R, Kiziltunc A. Vascular endothelial and basic fibroblast growth factor serum levels in patients with Behçet's disease. Rheumatol Int 2005; 25: 599-603.
10. Fine HF, Baffi J, Reed GF, Csaky KG, Nussenblatt RB. Aqueous humor and plasma vascular endothelial growth factor in uveitis-associated cystoid macular edema. Am J Ophthalmol 2001; 132: 794-6.
11. Baggiolini M, Loetscher P. Chemokines in inflammation and immunity. Immunol Today 2000; 21: 418-20.
12. Mo JS, Matsukawa A, Ohkawara S, Yoshinaga M. Role and regulation of IL-8 and MCP-1 in LPS-induced uveitis in rabbits. Exp Eye Res 1999; 68: 333-40.
13. Verma MJ, Lloyd A, Rager H, et al. Chemokines in acute anterior uveitis. Curr Eye Res 1997; 16: 1202-8.
14. Mo JS, Matsukawa A, Ohkawara S, Yoshinaga M. CXC chemokine GRO is essential for neutrophil infiltration in LPS-induced uveitis in rabbits. Exp Eye Res 2000; 70: 221-6.
15. Kaburaki T, Fujino Y, Kawashima H, et al. Plasma and whole-blood chemokine levels in patients with Behçet's disease. Graefes Arch Clin Exp Ophthalmol 2003; 241: 353-8.
16. Abu El-Asrar AM, Struyf S, Descamps FJ, et al. Chemokines and gelatinases in the aqueous humor of patients with active uveitis. Am J Ophthalmol 2004; 138: 401-11.
17. Gragoudas ES, Adamis AP, Cunningham ET, Jr., Feinsod M, Guyer DR. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 2004; 351: 2805-16.
18. Horuk R. Development and evaluation of pharmacological agents targeting chemokine receptors. Methods 2003; 29: 369-75.